Structuring your board for growth - 27/06/18

❰ Back

Bailey Fisher Executive Search is pleased to be presenting a panel discussion at Babraham Research Campus on Structuring your board for growth, offering insight and peer-to-peer discussion for CEOs, COOs & CFOs within growth life sciences businesses.  The line-up of speakers includes:

Dr Annalisa Jenkins, a life sciences thought leader with over 25 years of global pharmaceutical industry experience.  CEO of PlaqueTec, Annalisa previously served as CEO & President of Dimension Therapeutics, a leading gene therapy company acquired by Ultragenyx last year.  Prior leadership roles include Head of Global Research & Development and Executive Vice President Global Development & Medical at Merck Serono.  Annalisa is Executive Chair of Vium, based in the San Francisco Bay Area, and of UK-based Silence Therapeutics plc, where she is also currently fulfilling the CEO role.  She holds Non-Executive board roles with growth companies including Avrobio, iOX Therapeutics, Thrombolytic Science, Cocoon Biotech and Ardelyx.

Dr Mark Treherne, a seasoned CEO, founder and board member, with over 25 years of industrial R&D experience in the discovery and development of novel treatments for diseases with unmet needs. Following an early career at Pfizer, Mark founded Cambridge Drug Discovery in 1997 and served as CEO, leading the growth of the company to exit to BioFocus in 2001 for £28 million. Over the past 15 years, Mark has helped to raise over £150 million for various early-stage biotechnology companies and has served on the boards of 16 private and public companies. He is currently Chair of Talisman Therapeutics and NuVision, and CEO of Avilex Pharma.

The full line up of speakers will be announced shortly.

The event will take place on 13 November 2018, and will be presented in association with Mills & Reeve and Deloitte.

Attendance is by invitation.  If you are a CEO/COO/CFO interested in attending, or finding out more, please contact

Share Button
❰ Back